Aberdare gp ii llc - direct investment history in Enteromedics inc

Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc sold 235086 shares at $0 remaining shares owned 0

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 235086 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc sold 5327 shares at $0 remaining shares owned 0

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 5327 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc sold 237254 shares at $0 remaining shares owned 0

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 237254 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f5 represents shares held by aberdare ii annex fund, l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc sold 952972 shares at $0 remaining shares owned 0

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 952972 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc sold 21607 shares at $0 remaining shares owned 0

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 21607 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 41293

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 41293 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f6 immediately exercisable.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 937

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 937 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f6 immediately exercisable.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc bought 58091 shares remaining shares owned 58091

Common Stock Enteromedics Inc Etrm Transaction code: C Conversion of derivative security (usually options)

f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.
f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc bought 237254 shares remaining shares owned 362254

Common Stock Enteromedics Inc Etrm Transaction code: C Conversion of derivative security (usually options)

f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.
f5 represents shares held by aberdare ii annex fund, l.p.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc bought 1188058 shares remaining shares owned 1310288

Common Stock Enteromedics Inc Etrm Transaction code: C Conversion of derivative security (usually options)

f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.
f4 represents shares held by aberdare ventures ii, l.p.


Filed on 2007-11-20 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070726.txt Sec File: edgar/data/1352036/0001181431-07-070726-index.htm

2007-11-20 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc bought 26934 shares remaining shares owned 29704

Common Stock Enteromedics Inc Etrm Transaction code: C Conversion of derivative security (usually options)

f1 the convertible preferred stock automatically converted one-to-one into common stock upon completion of the initial public offering.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 41293

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 41293 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f6 immediately exercisable.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 937

Common Stock Warrant Enteromedics Inc Etrm exercise price 0.46 has valueitem expiration due date 2010-12-12 underlying security shares 937 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f6 immediately exercisable.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 235086

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 235086 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 5327

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 5327 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 237254

Series C Preferred Stock Enteromedics Inc Etrm underlying security shares 237254 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f5 represents shares held by aberdare ii annex fund, l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 952972

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 952972 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f4 represents shares held by aberdare ventures ii, l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.


Filed on 2007-11-19 by Aberdare Ii Annex Fund L P SEC CIK 1352036 Form 4

Accession 0001181431-07-070482.txt Sec File: edgar/data/1352036/0001181431-07-070482-index.htm

2007-11-15 Aberdare Gp Ii Llc (CIK 1418078) through Direct

Invested in Enteromedics Inc remaining shares owned 21607

Series B Preferred Stock Enteromedics Inc Etrm underlying security shares 21607 underlying security title Common Stock

f2 paul klingenstein, a director of enteromedics inc., is a managing partner and aberdare gp ii, llc is the general partner of each of aberdare ventures ii, l.p., aberdare ventures ii (bermuda), l.p. and aberdare ii annex fund, l.p.
f3 represents shares held by aberdare ventures ii (bermuda), l.p.
f1 the convertible preferred stock will automatically convert one-to-one into common stock upon completion of the initial public offering.